Dasotraline Improves Body Weight, Compulsive Behaviors in Binge Eating Disorder
Dasotraline may reduce compulsions and obsessive thoughts in adults with binge eating disorder.
US Psych Congress
Discontinuing Esketamine Nasal Spray Not Linked to Withdrawal Syndrome in Treatment-Resistant Depression
Discontinuing short- or long-term use of esketamine nasal spray for treatment-resistant depression may not be associated with withdrawal symptoms.
Relapse More Likely With Antipsychotic Switch in Schizophrenia, Bipolar Disorder, or MDD
Patients with schizophrenia or a mood disorder who switched antipsychotic treatment had an increased likelihood for relapse, healthcare resource utilization, and extrapyramidal symptoms.
New Medication Combination Promising for Adolescent Borderline Personality Disorder
Off-label use of oxcarbazepine and amantadine HCl appeared effective in maintaining improved symptomology in adolescent female patients with borderline personality disorder.
Undertreatment of ADHD in US Adults: An Unmet Need
Results indicate there is an unmet need for better treatment to manage symptom burden in US adults with ADHD.
Sexual Dysfunction in Patients With Major Depressive Disorder in Remission
Patients with MDD with or without sexual dysfunction were evaluated 2 months in remission and assessed with the Arizona Sexual Experience Scale.
Predictors of Optimal Schizophrenia Outcomes Using PP1M, PP3M Treatment
Researchers sought to examine the most efficacious treatment for clinical remission in adults with schizophrenia.
Cariprazine Effective for Long-Term Sustained Remission in Patients With Schizophrenia
Cariprazine treatment is associated with significantly higher rates of long-term sustained remission in patients with schizophrenia.
- Loading...
Loading...
Next post in Psych Congress 2017 Coverage
Loading... 
Loading...